Oncogenic Kras has a pivotal role in the carcinogenesis and progression of gastrointestinal tumors, such as those of the pancreas and colon, and in novel treatment options in Kras-mutant metastatic colorectal cancer. This evidence concerns the gene KRAS and digestive system neoplasm.